(RTTNews) - Mind Medicine (MindMed) Inc.(MNMD), a company focused on psychedelic-inspired therapies, said on Tuesday that Robert Barrow has been named as its new chief executive officer or CEO.
Barrow was serving as as interim CEO of MindMed after J.R. Rahn, resigned as the company's Co-Founder and CEO, earlier this year. Effective immediately, the company has also appointed Carol Vallone as Chair, to replace Perry Dellelce, who previously served as Director and Chairman.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
